BT-101 (Boost Pharma)

N/A

Report date: 2026/01/08 16:16:51

Base Information

Drug NameBT-101 (Boost Pharma)

Drug Alias NameCOL1A1/COL1A2 gene modulatorAllogeneic expanded human first trimester fetal liver-derived mesenchymal stem cellsBT-101

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Fetal-derivedCell and gene therapy > Cell therapy > Donor > Allogeneic

Mechanisms of ActionCollagen alpha-1(I) chain modulatorsCollagen alpha 2 chain modulators

TargetsCollagen alpha-1(I) chainCollagen alpha 2 chain

Therapy Area/IndicationsOsteogenesis Imperfecta

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySwedenIndia

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesKarolinska Institutet Boost Pharma APS

China Registration ClassN/A

Develop Information

Active CompaniesKarolinska Institutet

Inactive CompaniesN/A

Active IndicationsOsteogenesis Imperfecta

Inactive IndicationsN/A

Other Information

ATC CodeN/A